巴雷特食管生物标志物的识别与临床应用 - Suppr

Suppr

超能文献

Identification and clinical implementation of biomarkers for Barrett's esophagus.

作者信息

Varghese Sibu, Lao-Sirieix Pierre, Fitzgerald Rebecca C

机构信息

MRC Cancer Cell Unit, Hutchison-MRC Research Centre, Cambridge, UK.

出版信息

Gastroenterology. 2012 Mar;142(3):435-441.e2. doi: 10.1053/j.gastro.2012.01.013. Epub 2012 Jan 20.

DOI:10.1053/j.gastro.2012.01.013

PMID:22266150

Abstract

摘要

相似文献

Identification and clinical implementation of biomarkers for Barrett's esophagus.

Gastroenterology. 2012 Mar;142(3):435-441.e2. doi: 10.1053/j.gastro.2012.01.013. Epub 2012 Jan 20.

Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?

Curr Gastroenterol Rep. 2001 Oct;3(5):371-4. doi: 10.1007/s11894-001-0075-7.

American Gastroenterological Association technical review on the management of Barrett's esophagus.

Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031.

Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.

Curr Opin Gastroenterol. 2009 Jul;25(4):358-65. doi: 10.1097/MOG.0b013e32832c148f.

Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

World J Gastroenterol. 2012 Nov 21;18(43):6263-8. doi: 10.3748/wjg.v18.i43.6263.

Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.

World J Gastroenterol. 2013 Jan 28;19(4):536-41. doi: 10.3748/wjg.v19.i4.536.

Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.

Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31.

[Topic Complex VI: Barrett esophagus].

Z Gastroenterol. 2005 Feb;43(2):184-90. doi: 10.1055/s-2005-857876.

[Barrett's esophagus: diagnosis and therapy].

Praxis (Bern 1994). 2005 May 25;94(21):861-8. doi: 10.1024/0369-8394.94.21.861.

Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

World J Gastroenterol. 2010 Dec 7;16(45):5669-81. doi: 10.3748/wjg.v16.i45.5669.

引用本文的文献

Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis.

Am J Physiol Gastrointest Liver Physiol. 2022 Jul 1;323(1):G31-G43. doi: 10.1152/ajpgi.00321.2021. Epub 2022 Apr 19.

Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.

Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):95-111. doi: 10.1038/s41575-021-00531-4. Epub 2021 Nov 2.

CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.

Dig Dis Sci. 2020 Jul;65(7):1992-1998. doi: 10.1007/s10620-019-05914-x. Epub 2019 Nov 5.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1397-1404.e7. doi: 10.1016/j.cgh.2017.02.017. Epub 2017 Feb 24.

CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.

PLoS One. 2016 Sep 1;11(9):e0161967. doi: 10.1371/journal.pone.0161967. eCollection 2016.

Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Am J Surg Pathol. 2016 May;40(5):e45-66. doi: 10.1097/PAS.0000000000000598.

TissueCypher(™): A systems biology approach to anatomic pathology.

J Pathol Inform. 2015 Aug 31;6:48. doi: 10.4103/2153-3539.163987. eCollection 2015.

Emerging optical methods for surveillance of Barrett's oesophagus.

Gut. 2015 Nov;64(11):1816-23. doi: 10.1136/gutjnl-2013-306706. Epub 2015 May 14.

The epidemiology, diagnosis, and treatment of Barrett's carcinoma.

Dtsch Arztebl Int. 2015 Mar 27;112(13):224-33; quiz 234. doi: 10.3238/arztebl.2015.0224.

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Br J Cancer. 2015 Apr 14;112(8):1384-91. doi: 10.1038/bjc.2015.100. Epub 2015 Mar 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Identification and clinical implementation of biomarkers for Barrett's esophagus.

Gastroenterology. 2012 Mar;142(3):435-441.e2. doi: 10.1053/j.gastro.2012.01.013. Epub 2012 Jan 20.

Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?

Curr Gastroenterol Rep. 2001 Oct;3(5):371-4. doi: 10.1007/s11894-001-0075-7.

American Gastroenterological Association technical review on the management of Barrett's esophagus.

Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031.

Changes in screening, prognosis and therapy for esophageal adenocarcinoma in Barrett's esophagus.

Curr Opin Gastroenterol. 2009 Jul;25(4):358-65. doi: 10.1097/MOG.0b013e32832c148f.

Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.

World J Gastroenterol. 2012 Nov 21;18(43):6263-8. doi: 10.3748/wjg.v18.i43.6263.

Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.

World J Gastroenterol. 2013 Jan 28;19(4):536-41. doi: 10.3748/wjg.v19.i4.536.

Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.

Gastroenterol Clin North Am. 2015 Jun;44(2):299-315. doi: 10.1016/j.gtc.2015.02.005. Epub 2015 Mar 31.

[Topic Complex VI: Barrett esophagus].

Z Gastroenterol. 2005 Feb;43(2):184-90. doi: 10.1055/s-2005-857876.

[Barrett's esophagus: diagnosis and therapy].

Praxis (Bern 1994). 2005 May 25;94(21):861-8. doi: 10.1024/0369-8394.94.21.861.

Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.

World J Gastroenterol. 2010 Dec 7;16(45):5669-81. doi: 10.3748/wjg.v16.i45.5669.

引用本文的文献

Molecules involved in the development of Barrett's esophagus phenotype in chronic eosinophilic esophagitis.

Am J Physiol Gastrointest Liver Physiol. 2022 Jul 1;323(1):G31-G43. doi: 10.1152/ajpgi.00321.2021. Epub 2022 Apr 19.

Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy.

Nat Rev Gastroenterol Hepatol. 2022 Feb;19(2):95-111. doi: 10.1038/s41575-021-00531-4. Epub 2021 Nov 2.

CDX-2 Expression in Esophageal Biopsies Without Goblet Cell Intestinal Metaplasia May Be Predictive of Barrett's Esophagus.

Dig Dis Sci. 2020 Jul;65(7):1992-1998. doi: 10.1007/s10620-019-05914-x. Epub 2019 Nov 5.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1397-1404.e7. doi: 10.1016/j.cgh.2017.02.017. Epub 2017 Feb 24.

CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression.

PLoS One. 2016 Sep 1;11(9):e0161967. doi: 10.1371/journal.pone.0161967. eCollection 2016.

Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Am J Surg Pathol. 2016 May;40(5):e45-66. doi: 10.1097/PAS.0000000000000598.

TissueCypher(™): A systems biology approach to anatomic pathology.

J Pathol Inform. 2015 Aug 31;6:48. doi: 10.4103/2153-3539.163987. eCollection 2015.

Emerging optical methods for surveillance of Barrett's oesophagus.

Gut. 2015 Nov;64(11):1816-23. doi: 10.1136/gutjnl-2013-306706. Epub 2015 May 14.

The epidemiology, diagnosis, and treatment of Barrett's carcinoma.

Dtsch Arztebl Int. 2015 Mar 27;112(13):224-33; quiz 234. doi: 10.3238/arztebl.2015.0224.

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.

Br J Cancer. 2015 Apr 14;112(8):1384-91. doi: 10.1038/bjc.2015.100. Epub 2015 Mar 17.